C4X Discovery signs licensing deal with Sanofi worth up to $492 mln

C4X Discovery Holdings

12/04/2021 07:46

April 12 (Reuters) - Drug developer C4X Discovery  C4XD.L 
said on Monday it has signed an exclusive licensing deal worth
up to 414 million euros ($492.12 million) with French drugmaker
Sanofi  SASY.PA  to develop an oral therapy for treatment of
inflammatory diseases.
    A unit of the London-listed company will get an upfront
payment of 7 million euros and receive up to a further 407
million euros for potential development, regulatory and
commercialisation milestones. 

 ($1 = 0.8413 euros)

 (Reporting by Yadarisa Shabong in Bengaluru; Editing by Shounak
Dasgupta)
 ((Yadarisa.Shabong@thomsonreuters.com; Twitter: https://twitter.com/Yadarisa;
 +919742735150))